HomeCompareVARTY vs MRK

VARTY vs MRK: Dividend Comparison 2026

VARTY yields 952.38% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VARTY wins by $12332448.55M in total portfolio value
10 years
VARTY
VARTY
● Live price
952.38%
Share price
$0.21
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12332448.61M
Annual income
$10,221,241,957,700.52
Full VARTY calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — VARTY vs MRK

📍 VARTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVARTYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VARTY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VARTY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VARTY
Annual income on $10K today (after 15% tax)
$80,952.38/yr
After 10yr DRIP, annual income (after tax)
$8,688,055,664,045.44/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, VARTY beats the other by $8,688,055,655,448.73/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VARTY + MRK for your $10,000?

VARTY: 50%MRK: 50%
100% MRK50/50100% VARTY
Portfolio after 10yr
$6166224.33M
Annual income
$5,110,620,983,907.15/yr
Blended yield
82.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VARTY
No analyst data
Altman Z
-1.8
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VARTY buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVARTYMRK
Forward yield952.38%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$12332448.61M$57.7K
Annual income after 10y$10,221,241,957,700.52$10,113.78
Total dividends collected$12170002.88M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VARTY vs MRK ($10,000, DRIP)

YearVARTY PortfolioVARTY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$105,938$95,238.10$11,213$373.04+$94.7KVARTY
2$1,056,283$942,929.20$12,667$512.06+$1.04MVARTY
3$9,916,875$8,786,651.85$14,439$708.14+$9.90MVARTY
4$87,707,472$77,096,416.11$16,640$988.16+$87.69MVARTY
5$731,100,427$637,253,432.49$19,432$1,394.07+$731.08MVARTY
6$5,746,701,273$4,964,423,815.28$23,057$1,992.90+$5746.68MVARTY
7$42,618,205,654$36,469,235,291.84$27,889$2,894.79+$42618.18MVARTY
8$298,367,923,577$252,766,443,527.28$34,518$4,286.29+$298367.89MVARTY
9$1,973,090,326,149$1,653,836,647,921.55$43,912$6,494.35+$1973090.28MVARTY
10$12,332,448,606,679$10,221,241,957,700.52$57,714$10,113.78+$12332448.55MVARTY

VARTY vs MRK: Complete Analysis 2026

VARTYStock

Varta AG, through its subsidiaries, researches, develops, produces, and sells microbatteries, household batteries, and energy storage solutions worldwide. It operates in two segments, Lithium-Ion Solutions & Microbatteries and Household Batteries. The Lithium-Ion Solutions & Microbatteries segment offers zinc-air batteries primarily for use in hearing aid devices; lithium-ion battery solutions for wireless headphones; wearables, which include medical devices to measure hypertension, blood sugar, and other bodily functions, as well as the power supply for COVID19 antibody tests; and rechargeable battery solutions for industrial and original equipment manufacturers for use in various applications, such as servers, car keys, alarm systems, or smart meters. This segment is also involved in the development, system integration, and assembly of lithium-ion battery packs for portable industrial, communication devices, electric power tool, home, garden, and medical applications. The Household Batteries segment offers household batteries, rechargeable batteries, chargers, power banks, lights, and energy storage systems. The company was founded in 1887 and is headquartered in Ellwangen, Germany. Varta AG is a subsidiary of Montana Tech Components AG.

Full VARTY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VARTY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VARTY vs SCHDVARTY vs JEPIVARTY vs OVARTY vs KOVARTY vs MAINVARTY vs JNJVARTY vs ABBVVARTY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.